AI Summary
We reviewed 56 live results for basalog insulin glargine and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Diabetes Care and Long Acting Insulin.
We reviewed 56 live results for basalog insulin glargine and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Diabetes Care and Long Acting Insulin.
Source: Biocon Biologics Philippines Inc.
Description
Basalog is a long-acting insulin glargine analog designed for consistent diabetes management and is part of affordability initiatives in the Philippines.
Best for
Long Acting insulin needs, Diabetes maintenance and Budget Conscious patients
Rating
Source: Eli Lilly (Philippines), Inc.
Description
Basaglar is a long-acting insulin glargine solution available in 100 Units/mL for the effective management of diabetes.
Best for
Diabetic patients, Glycemic control and Long Term insulin maintenance
Rating
Source: Public Healthcare Institutions
Description
Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals.
Best for
Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans and Government Subsidized medication
Rating
| Compare | Basalog (Insulin Glargine) | Basaglar (Insulin Glargine) | Subsidised Insulin Glargine (Lantus) Dispensing |
|---|---|---|---|
| Source | Biocon Biologics Philippines Inc. | Eli Lilly (Philippines), Inc. | Public Healthcare Institutions |
| Description | Basalog is a long-acting insulin glargine analog designed for consistent diabetes management and is part of affordability initiatives in the Philippines. | Basaglar is a long-acting insulin glargine solution available in 100 Units/mL for the effective management of diabetes. | Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals. |
| Best for | Long Acting insulin needs, Diabetes maintenance and Budget Conscious patients | Diabetic patients, Glycemic control and Long Term insulin maintenance | Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans and Government Subsidized medication |
| Action | |||
| Rating |
If you want the most balanced option to start with, I recommend:
"Basalog (Insulin Glargine) from Biocon Biologics Philippines Inc.."
I picked this because Basalog is featured in the 'Mission 10 Cents' initiative, making it a highly cost-effective choice for long-term diabetes care.
Note: TopFind provides comparison information for general research purposes only.